Arrowhead Secures a Commitment of Up to $2 Billion from Novartis for siRNA Initiative Targeting Parkinson’s Disease

Arrowhead Secures a Commitment of Up to $2 Billion from Novartis for siRNA Initiative Targeting Parkinson’s Disease

Arrowhead Secures a Commitment of Up to $2 Billion from Novartis for siRNA Initiative Targeting Parkinson’s Disease